This structured review identifies and highlights the 10 original research articles most likely to reduce overuse of medical care.
The commentary discusses the implications of the study on anticoagulant therapy for splanchnic vein thrombosis from the International Society on Thrombosis and Hemostasis registry.
This cohort study evaluates the long-term outcomes of splanchnic vein thrombosis in patients with differing risk factors and treatments.
This cohort study notes an increased risk of bleeding in patients receiving bridge therapy during warfarin interruption for invasive procedures.
This study examines the change in proportion of atrial fibrillation patients eligible for anticoagulation before and after the 2014 revision of the AHA/ACC/HRS anticoagulation guidelines.
Bashir and colleagues compare in-hospital outcomes in the treatment of acute proximal deep vein thrombosis using anticoagulation plus catheter-directed thrombolysis (CDT) vs anticoagulation alone. They also evaluate the temporal trends in CDT utilization and outcomes in proximal DVT treatment.
Albrecht et al estimate the risk of thrombotic and hemorrhagic events associated with warfarin therapy resumption following traumatic brain injury.
Stergiopoulos and Brown compare genotype-guided initial dosing of warfarin and its analogues with clinical dosing protocols. See also the Invited Commentary by Kazi and Hlatky.
Lamontagne and colleagues describe the frequency, anatomical location, risk factors, management, and consequences of nonleg deep venous thromboses in a large cohort of medical-surgical critically ill adults. Maynard provides an Invited Commentary.